Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

NCT06831058 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT06831058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06831058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Recruiting
Start date
May 1, 2025
Completion date
May 1, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune-mediated thrombotic thrombocytopenic purpura